P. Berclaz

发表

Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

H. Nakagawa, T. Ishii, M. Heffernan, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Chapter 52 – Rare Childhood Lung Disorders: α1-Antitrypsin Deficiency, Pulmonary Alveolar Proteinosis, and Pulmonary Alveolar Microlithiasis

B. Trapnell, P. Berclaz, 2006 .

AIR Inhaled Insulin Versus Subcutaneous Insulin

M. Wolzt, F. Tibaldi, D. Muchmore, 2008, Diabetes Care.

Altered Postnatal Lung Development in C3H/HeJ Mice

T. Korfhagen, V. Sampath, J. Kitzmiller, 2006, Pediatric Research.

OP0021 A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: Naïve to biologic therapy or inadequate responders to tumor necrosis factor alpha inhibitors

M. Genovese, D. Braun, G. Cameron, 2013 .

Changes in Protein Turnover and Resting Energy Expenditure after Treatment of Malaria in Gambian Children

E. Jéquier, Y. Schutz, C. Benedek, 1996, Pediatric Research.

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study

J. Buyon, T. Dörner, J. Merrill, 2015, Annals of the rheumatic diseases.

Efficacy and Safety of Tabalumab, an Anti–B-Cell–Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)

M. Genovese, P. Emery, G. Silverman, 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors

M. Genovese, S. Myers, R. Fleischmann, 2012, Annals of the rheumatic diseases.

Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.

J. Gross, Z. Milicevic, J. Tobian, 2009, Diabetes technology & therapeutics.

Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.

S. Garg, C. Mathieu, J. Gates, 2009, Diabetes technology & therapeutics.

Quality control of DL,CO instruments in global clinical trials

R. Crapo, P. Berclaz, R. Jensen, 2009, European Respiratory Journal.

A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell–activating factor monoclonal antibody, for rheumatoid arthritis

L. Szczepański, M. Greenwald, P. Berclaz, 2014, Arthritis Research & Therapy.

Resting metabolic rate and protein turnover in apparently healthy elderly Gambian men.

E. Jéquier, Y. Schutz, C. Benedek, 1995, The American journal of physiology.

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

B. Trapnell, L. Denson, M. Filippi, 2007, The New England journal of medicine.

Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.

S. Suter, M. Chanson, A. Pavirani, 2001, The American journal of pathology.

Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study

J. Kremer, T. Huizinga, T. Dörner, 2015, RMD Open.

Standardized procedure for measurement of nasal potential difference: An outcome measure in multicenter cystic fibrosis clinical trials

J. Emerson, M. Knowles, M. Konstan, 2004, Pediatric pulmonology.

GRANULOCYTE-MACROPHAGE-COLONY-STIMULATING FACTOR-DEPENDENT PERITONEAL MACROPHAGE RESPONSES DETERMINE SURVIVAL IN EXPERIMENTALLY INDUCED PERITONITIS AND SEPSIS IN MICE

B. Trapnell, T. Shanley, Bin Zhao, 2008, Shock.

GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.

J. Whitsett, B. Trapnell, M. O’connor, 2007, American journal of respiratory cell and molecular biology.

Alveolar Macrophages by GM-CSF and PU.1 Organization Are Coordinately Regulated in Nonspecific Phagocytosis, and Cytoskeletal Endocytic Internalization of Adenovirus,

J. Whitsett, B. Trapnell, Y. Shibata, 2002 .

No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations.

R. Gibson, J. Clancy, Z. Bebők, 2007, American journal of respiratory cell and molecular biology.

Internalization of Adenovirus by Alveolar Macrophages Initiates Early Proinflammatory Signaling during Acute Respiratory Tract Infection

B. Trapnell, Z. Zsengellér, P. Berclaz, 2000, Journal of Virology.

Detection of Enteroviruses in the Cerebrospinal Fluid by Polymerase Chain Reaction: Prospective Study of Impact on the Management of Hospitalized Children

S. Suter, C. Siegrist, W. Wunderli, 2000, Clinical pediatrics.

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study

D. M. van der Heijde, M. Weinblatt, C. Bingham, 2014, Annals of the rheumatic diseases.

A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate

M. Genovese, S. Myers, J. Satterwhite, 2013, Annals of the rheumatic diseases.

Rho GTPase Rac1 is critical for neutrophil migration into the lung.

M. Filippi, C. Harris, P. Berclaz, 2007, Blood.

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

J. Whitsett, B. Trapnell, Y. Shibata, 2001, Immunity.

Biomass-fueled Intervention Stoves in the Developing World

B. Trapnell, D. Pittet, S. Abe, 2009 .

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

M. Genovese, D. Braun, G. Cameron, 2014, Arthritis & rheumatology.

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

M. Genovese, E. Keystone, P. Taylor, 2014, Annals of the rheumatic diseases.

Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis

J. Erickson, M. Genovese, D. Braun, 2016, The Journal of Rheumatology.

The impact of diabetes and age on pulmonary function: data from the National Health and Nutrition Examination Survey.

R. Crapo, R. Jensen, J. Tobian, 2009, Diabetes research and clinical practice.

Endocytic Internalization of Adenovirus, Nonspecific Phagocytosis, and Cytoskeletal Organization Are Coordinately Regulated in Alveolar Macrophages by GM-CSF and PU.11

J. Whitsett, B. Trapnell, Y. Shibata, 2002, The Journal of Immunology.

Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis.

H. Genant, J. Krege, K. Krohn, 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

DURATION-DEPENDENT CYTOPROTECTIVE VERSUS INFLAMMATORY EFFECTS OF LUNG EPITHELIAL FIBROBLAST GROWTH FACTOR-7 EXPRESSION

J. Tichelaar, J. Whitsett, M. Sartor, 2007, Experimental lung research.

GM-CSF, via PU.1, regulates alveolar macrophage FcγR-mediated phagocytosis and the IL-18/IFN-γ–mediated molecular connection between innate and adaptive immunity in the lung

J. Whitsett, B. Trapnell, Y. Shibata, 2002 .

GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung.

J. Whitsett, B. Trapnell, Y. Shibata, 2002, Blood.

Clinical Issues Relationship Between Vertebral Fracture Burden , Height Loss , and Pulmonary Function in Postmenopausal Women With Osteoporosis

H. Genant, J. Krege, K. Krohn, 2022 .

Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.

M. Lawrence, C. Heilmann, J. Tobian, 2009, Diabetes technology & therapeutics.

A new device for in vivo measurement of nasal transepithelial potential difference in cystic fibrosis patients and normal subjects.

T. Rochat, J. Lacroix, D. Belli, 1997, European Respiratory Journal.

Oral Abstracts 7: RA ClinicalO37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach

H. L. Wright, R. Moots, T. Spector, 2013 .

Ef ﬁ cacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study

R. Ortmann, P. Berclaz, W. Komocsar, 2022 .